[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-506451-105":59,"doc-detail-506451-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","critical-congenital-heart-disease-pulse-oximetry-screening-protocol-v17-january-2025","Critical Congenital Heart Disease Pulse Oximetry Screening Protocol - v17 - January 2025","","Provides a standardized methodology for performing and evaluating the Critical Congenital Heart Disease (CCHD) pulse oximetry screening test in asymptomatic newborns. It defines purpose, scope, responsibilities, and key terms, and instructs staff on parental education, consent, timing (ideally 24–48 hours of age), probe placement, signal quality, measurement procedures, and documentation. Results are interpreted using the NSO approved CCHD algorithm and referral requirements, distinguishing screen negative from screen positive pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/critical-congenital-heart-disease-pulse-oximetry-screening-protocol-v17-january-2025/506451/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/critical-congenital-heart-disease-pulse-oximetry-screening-protocol-v17-january-2025/506451.png","ImageObject",300,407,{"name":92,"@type":93},"BigDaveOnline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-08","2026-10-05",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"When should a CCHD pulse oximetry screen be performed for newborns?","Question",{"text":112,"@type":113},"Ideally between 24 and 48 hours post-delivery, with an optimal window of 24 to 36 hours. Screens before 24 hours have a higher false positive rate.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is the pulse oximeter probe placed for pre-ductal and post-ductal measurements?",{"text":117,"@type":113},"Place the probe on the RIGHT hand for pre-ductal SpO2 and on EITHER foot for post-ductal SpO2, aligning the light emitter and photodetector portions.",{"name":119,"@type":110,"acceptedAnswer":120},"What criteria determine a screen positive result and what follow-up is required?",{"text":121,"@type":113},"A screen is positive if SpO2 is less than 90% in the right hand or either foot, or less than 95% on both extremities, or the SpO2 difference is greater than 3% between the right hand and either foot for 3 consecutive measures separated by 1 hour. Notify the most responsible practitioner and make an urgent referral within 6–8 hours for further investigation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},506451,1791443373,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144},962090896214,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Title: Critical Congenital Heart Disease Pulse Oximetry Screening Protocol  \nPurpose:  \n• To ensure a consistent and effective methodology for performing and evaluating a Critical Congenital Heart Disease (CCHD) pulse oximetry screen on a newborn.  \nScope or Principle:  \nThis protocol outlines the Newborn Screening Ontario (NSO) guideline for performing and evaluating a CCHD screen on a newborn. Health Care Providers (HCPs) will screen all newborns ideally between 24 and 48 hours post-delivery for CCHD using the NSO approved algorithm.  \nBackground:  \nCCHD screening in asymptomatic newborns can assist in the early identification and treatment of CCHD, resulting in better outcomes for affected babies. It is important to note that this is a screening test performed on well babies and is not a diagnostic test.  \nResponsibility:  \nHCPs caring for newborns including but not limited to nurses and midwives, during the first days of life should be familiar with the protocol. The screener should possess the knowledge, skill, and judgement to offer and perform CCHD screening along with CCHD screening education for parents/families. It is one component of the clinical picture. The screen result must be considered alongside an assessment by or under direct supervision of someone capable of interpreting the result within the complete clinical picture.  \nDefinitions/Acronyms:  \n• NSO = Newborn Screening Ontario  \n• CCHD = Critical Congenital Heart Disease  \n• HCP = Health Care Provider  \n• SpO2 = Saturation of pulse oximetry, measurement of oxygen saturation  \n• NICU/SCN/PICU = Neonatal Intensive Care Unit/Special Care Nursery/Paediatric Intensive Care Unit  \n• DBS card = Dried Blood Spot card  \n• CCHD screen = a non-invasive comparative pre and post-ductal pulse oximetry test  \nperformed on an asymptomatic newborn as an identifier of possible cardiac issues  \nRelated Documentation:  \n• Newborn Screening Ontario Critical Congenital Heart Disease Pulse Oximetry Screening  \n– NICU/SCN/PICU Babies Protocol  \n• Newborn Screening Ontario Critical Congenital Heart Disease Pulse Oximetry Screening  \n– Early Discharge Protocol  \n• Newborn Screening Ontario Critical Congenital Heart Disease Pulse Oximetry Screening  \n– Community Screening Protocol (Non-Hospital Setting)  \n• Newborn Screening Ontario Critical Congenital Heart Disease Pulse Oximetry Screening  \n– Screen Positive Workup Protocol  \nProcedure:  \nScreening  \n1. Provide education explaining the purpose and benefit of CCHD screening to parents/families of newborn. Obtain consent to perform the screen.  \na. Include the following in the explanation: The screen is non-invasive and pain free, involves oxygen measurements in the right hand and either foot. The values are compared and then evaluated. This evaluation can give us information about the newborn’s oxygen levels. The screen is not diagnostic but can indicate more testing is necessary.  \n2. Perform the CCHD screen using pulse oximetry ideally when the newborn is between 24 and 48 hours of age, with an optimal window of between 24 and 36 hours of age. Screens performed prior to 24 hours of age have been shown to demonstrate a higher false positive rate than screens performed in the suggested 24-48 hour window.  \n3. Position the pulse oximeter probe on the RIGHT hand for a pre-ductal oxygen saturation measurement (SpO2) and on EITHER foot for a post-ductal oxygen saturation measurement (SpO2). Align the light emitter portion of the pulse oximeter probe facing the photodetector portion of the pulse oximeter probe.  \n4. Perform the CCHD screen consecutively, the first measurement directly followed by the second measurement.  \n5. Conduct the CCHD screen using a motion tolerant pulse oximeter approved by or provided by NSO.  \n6. The newborn should ideally be in a quiet, non-fussing state. Complete the CCHD screen prior to any invasive procedure or care activity that disturbs the infant.  \n7. Once a reliable signal is obtained (this will be ev","cbCaiuUtaDE2NVfM","https://ap.wps.com/l/cbCaiuUtaDE2NVfM","pdf",985969,"English","# Purpose\n# Scope or Principle\n# Responsibility\n# Definitions/Acronyms\n# Procedure\n## Screening\n## Evaluation of Results\n## Evaluation of Screening Values","[{\"question\":\"When should a CCHD pulse oximetry screen be performed for newborns?\",\"answer\":\"Ideally between 24 and 48 hours post-delivery, with an optimal window of 24 to 36 hours. Screens before 24 hours have a higher false positive rate.\"},{\"question\":\"How is the pulse oximeter probe placed for pre-ductal and post-ductal measurements?\",\"answer\":\"Place the probe on the RIGHT hand for pre-ductal SpO2 and on EITHER foot for post-ductal SpO2, aligning the light emitter and photodetector portions.\"},{\"question\":\"What criteria determine a screen positive result and what follow-up is required?\",\"answer\":\"A screen is positive if SpO2 is less than 90% in the right hand or either foot, or less than 95% on both extremities, or the SpO2 difference is greater than 3% between the right hand and either foot for 3 consecutive measures separated by 1 hour. Notify the most responsible practitioner and make an urgent referral within 6–8 hours for further investigation.\"}]","Critical Congenital Heart Disease Pulse Oximetry Screening Protocol - v17 - January 2025 | PDF",1791165449,18]